유방암 환자를 위한 당뇨병 관리

실험적: 간호사-개업의 주도 개입 그룹

종양학 팀에서 당뇨병 훈련을 받은 전문간호사(NP)가 암 치료를 받는 유방암 환자의 당뇨병 관리를 도울 것입니다.

행동: 개업의 주도 개입

• PALS(Patient Activated Learning System)를 통한 개별화된 권장 사항/약물 및 환자 교육을 통한 화학 요법 주입 중 NP와의 대면 또는 가상 상담.
• 12주/화학 요법 과정 동안 전화, Zoom 또는 대면(환자 지시)을 통한 NP의 주간 후속 조치.

간섭 없음: 비개입(통제) 그룹

환자는 간호사가 주도하는 개입에 접근할 수 없습니다.

채용성공률

모집된 참가자 수를 접근한 참가자 수로 나눈 값

데이터 수집 성공률

두 설문 조사를 완료한 참가자 수를 등록된 참가자 수로 나눈 값입니다.

Intervention Completion Ratio

(Intervention only) Number of participants who completed the intervention divided by the number of participants who were enrolled.

Patient Questionnaire: Self-report of Intervention Feasibility

Questionnaire: Feasibility of Intervention Measure (4 items)

Response Scale:

For each item, respondents can choose a value from 1-5. Scales can be created for the measure by averaging responses for all 4 items for the overall score. The average score range is from 1 to 5 with higher scores indicating that the intervention is very feasible, and lower scores (below 3) indicating the intervention is not feasible.

Patient Questionnaire: Self-report of Intervention Acceptability

Questionnaire: Acceptability of Intervention Measure (4 items)

Response Scale:

For each item, respondents can choose a value from 1-5. Scales can be created for the measure by averaging responses for all 4 items for the overall score. The average score range is from 1 to 5 with higher scores indicating more favorable attitudes toward the intervention and lower scores (below 3) indicating less favorable attitudes.

Patient Questionnaire: Self-report of Intervention Appropriateness

Questionnaire: Intervention Appropriateness Measure (4 items)

Response Scale:

For each item, respondents can choose a value from 1-5. Scales can be created for the measure by averaging responses for all 4 items for the overall score. The average score range is from 1 to 5 with higher scores indicating the intervention suits their needs well and lower scores (below 3) indicating the intervention does not fit their needs well.

Ratio of Patients Who Had a Summary Document Created for Them at the End of the Intervention

Number of patients who had a summary document created for them compared to the number of patients who complete the follow-up visit.

Mean Number of In-person, Virtual or Phone Contacts With the NP Per Participant.

This will assess the degree to which the intervention was implemented over the course of the study

당뇨병 치료 만족도 설문지의 환자 자기보고 응답의 변화

당뇨병 치료 만족도 설문지(8개 항목) DTSQ, 점수 0-36; 높은 만족도를 반영하는 높은 점수

암 치료-유방 설문지의 기능적 평가에 대한 환자 자기보고 응답의 변화

암 치료의 기능 평가 -Breast(44개 항목)는 유방암 환자의 삶의 질을 측정합니다. 총 점수 범위는 0-148이며 점수가 높을수록 삶의 질이 더 우수함을 나타냅니다.

Severity of Patient Self-report Responses of Neuropathy as Measured By the PRO-CTCAE Survey at Follow-up

PRO-CTCAE: Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events

Neuropathy - PRO-CTCAE (2 items) 0-8 with higher scores representing worse neuropathy

Change in Patient Self-report Responses of Diabetes Distress Scale Questionnaire

Diabetes Distress Scale (17 items) A score of "1" indicates a particular item is not a problem or bother for the patient, whereas "6" represents an item is very concerning for the patient. To score, the patient's responses will be summed and then divided by the number of items in that scale. A mean score of 3 or higher (moderate distress) is considered as a level of distress that is above average. (decrease in score means the item is considered less of a problem/bother)

Average Number of Hospitalizations Since Study Enrollment

The average number of hospitalizations since study enrollment

Average Number of ED Visits Since Study Enrollment

The average number of emergency department (ED) visits since study enrollment

Average Number of Uncompleted Chemotherapy Sessions

Average number of planned chemo sessions that were not completed by participants

Proportion of Planned Chemo Session Completed (%)

The proportion of planned chemo session completed during study enrollment, as a percentage

Chemo Dose Reduction

Whether or not participants had their chemotherapy dose reduced

Most Recent HbA1c Level

Average last HbA1c level

Highest Glucose During Treatment

Average highest glucose measure during treatment